323,81 €
359,79 €
-10% with code: EXTRA
Predictive Approaches in Drug Discovery and Development
323,81 € 
- We will send in 10–14 business days.
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives…
/images/books/3578495/9780470170830.jpg)
- Author: J Andrew Williams
- Publisher: Wiley
- ISBN-10: 0470170832
- ISBN-13: 9780470170830
- Format: 16.3 x 23.6 x 2.8 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Predictive Approaches in Drug Discovery and Development (e-book) (used book) | bookbook.eu
Reviews
Description
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.EXTRA 10 % discount with code: EXTRA
323,81 €
359,79 €
We will send in 10–14 business days.
The promotion ends in 19d.21:59:23
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: J Andrew Williams
- Publisher: Wiley
- ISBN-10: 0470170832
- ISBN-13: 9780470170830
- Format: 16.3 x 23.6 x 2.8 cm, hardcover
- Language: English English
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers. Case histories and lessons from successful and unsuccessful applications of biomarkers are included along with key chapters on GLP validation, safety biomarkers and proteomics biomarkers. Regulatory agency perspectives and initiatives both in the US and internationally are also discussed.
Reviews